feed,title,long_url,short_url
Benzinga,Novartis' Beovu Non-Inferior To Aflibercept In Phase 3 Diabetic Macular Edema Study,https://benzinga.com/general/biotech/21/05/20911088/novartis-beovu-non-inferior-to-aflibercept-in-phase-3-diabetic-macular-edema-study,https://j.mp/3gS7cxk
